- Home
- AVXL vs HCKT Comparison
AVXL vs HCKT Comparison
Compare AVXL & HCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVXL
- HCKT
- Stock Information
- Founded
- AVXL 2004
- HCKT 1991
- Country
- AVXL United States
- HCKT United States
- Employees
- AVXL N/A
- HCKT N/A
- Industry
- AVXL Biotechnology: Biological Products (No Diagnostic Substances)
- HCKT Professional Services
- Sector
- AVXL Health Care
- HCKT Consumer Discretionary
- Exchange
- AVXL Nasdaq
- HCKT Nasdaq
- Market Cap
- AVXL 794.0M
- HCKT 649.9M
- IPO Year
- AVXL N/A
- HCKT 1998
- Fundamental
- Price
- AVXL $9.32
- HCKT $25.42
- Analyst Decision
- AVXL Strong Buy
- HCKT Strong Buy
- Analyst Count
- AVXL 2
- HCKT 3
- Target Price
- AVXL $44.00
- HCKT $31.33
- AVG Volume (30 Days)
- AVXL 927.5K
- HCKT 207.2K
- Earning Date
- AVXL 08-05-2025
- HCKT 08-05-2025
- Dividend Yield
- AVXL N/A
- HCKT 1.89%
- EPS Growth
- AVXL N/A
- HCKT N/A
- EPS
- AVXL N/A
- HCKT 0.84
- Revenue
- AVXL N/A
- HCKT $307,532,000.00
- Revenue This Year
- AVXL N/A
- HCKT $6.06
- Revenue Next Year
- AVXL N/A
- HCKT $5.46
- P/E Ratio
- AVXL N/A
- HCKT $30.24
- Revenue Growth
- AVXL N/A
- HCKT 3.49
- 52 Week Low
- AVXL $4.00
- HCKT $21.12
- 52 Week High
- AVXL $14.44
- HCKT $34.02
- Technical
- Relative Strength Index (RSI)
- AVXL 60.62
- HCKT 55.97
- Support Level
- AVXL $9.09
- HCKT $24.82
- Resistance Level
- AVXL $9.78
- HCKT $25.59
- Average True Range (ATR)
- AVXL 0.41
- HCKT 0.56
- MACD
- AVXL 0.09
- HCKT 0.18
- Stochastic Oscillator
- AVXL 71.58
- HCKT 81.03
About AVXL Anavex Life Sciences Corp.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.
About HCKT Hackett Group Inc (The).
The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.